Press

News, Optichannel excellence, Product announcement

PharmaForceIQ Acquires Aktana to Deliver Unparalleled Cross-Functional Engagement Impact for Pharma

HCP engagement, Optichannel excellence

Maximizing ROI with optichannel marketing

Learn how optichannel marketing uses data and precise targeting to improve pharma engagement, reduce waste, and increase measurable ROI.

Launch planning, Optichannel excellence, Understanding ROI

Before and after optichannel: Rescuing a stalled launch in 5 months

See how affinity intelligence and optichannel precision helped a pharma brand turn around a stalled launch and accelerate adoption in five months.

Customer journeys, HCP engagement, Media efficiency

Small budget, big lift: Hyper-targeting supercharges always-on campaigns

See how hyper-targeted tactics helped a pharma team respond to competitive pressure and field vacancies while maximizing HCP engagement.

Optichannel excellence, Patient engagement

Strategic advantage: Optichannel engagement drives ROI across the product lifecycle

Read how optichannel engagement connects personal and nonpersonal efforts from pre-launch planning through pharma brand growth.

Life science trends, News

PharmaForceIQ Announces Substantial Growth as It Expands Optichannel Engagement Solutions

PharmaForceIQ reports accelerated growth as it expands data-driven optichannel engagement solutions for life sciences teams.

Audience insights, Optichannel excellence

PM360: The Efficiency Trifecta: Keys to Maximizing Pharma Marketing ROI

Hemal Somaiya shares insights in PM360 on how agile pharma marketing strategies, real-time data, and AI-powered precision are transforming ROI for marketers.

Life science trends, News, Optichannel excellence

PharmaForceIQ’s Hemal Somaiya Honored as a ‘Disrupter’ in the 2025 PM360 ELITE 100 Awards

Chief Strategy Officer, Hemal Somaiya, has been selected by PM360 as an honoree in the ‘Disrupter’ category of the 2025 PM360 ELITE 100 program.

Life science trends, News, Optichannel excellence

PharmaForceIQ’s Hemal Somaiya Recognized As One Of MM+M’s ‘Women Of Distinction’ For 2025

PharmaForceIQ is pleased to announce that executive Hemal Somaiya has been selected by MM+M as an honoree in the 2025 Women of Distinction program.

Life science trends, News

PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth

PharmaForceIQ's majority investment from Eir Partners supports growth and broader adoption of its pharma customer engagement platform.